Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2013 Feb;89(2):81-6.
doi: 10.1016/j.earlhumdev.2012.08.001. Epub 2012 Sep 20.

Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors

Megan V Smith  1 , Anita Sung, Bhavesh Shah, Linda Mayes, Deborah S Klein, Kimberly A Yonkers
Affiliations
Controlled Clinical Trial

Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors

Megan V Smith et al. Early Hum Dev. 2013 Feb.

Abstract

Background: Some studies report neurobehavioral symptoms in neonates exposed to serotonin reuptake inhibitors (SRIs) in utero. However, maternal psychiatric illness during the last trimester of pregnancy, as a confounding factor, has not always been assessed.

Aims: In this prospective study we compared neurobehavioral complications among neonates who were born to euthymic women who either took or did not take an SRI during the last trimester of pregnancy.

Study design: Exposed and unexposed infants were assessed for: 1) temperament as measured by the Neonatal Behavioral Assessment Scale (NBAS); 2) activity via Actiwatch electronic monitoring; 3) sleep state using trained observer ratings; and 4) perinatal complications through medical record review. T-tests, Fisher's exact tests, and analyses of covariance were used to assess the relationship between clinical and neurobehavioral factors and exposure status.

Subjects: 67 infants (61 controls and 6 exposed to SRIs).

Outcome measures: Neonatal Assessment Behavioral Scale, APGAR scores, infant sleep state (% sleep, % wakeful), startles and tremulousness, gestational age, birth weight, and head circumference.

Results: Infants exposed to SRIs in the third trimester had poorer motor development, lower 5-minute APGAR scores, and shorter mean gestational age as compared to unexposed infants.

Conclusion: Results of this study show differences in autonomic and gross motor activity between neonates who were or were not exposed to SRIs in utero after controlling for active maternal psychiatric illness. Future longitudinal work should compare longer term outcomes of exposed and unexposed infants of depressed mothers.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

Dr. Yonkers has the following conflicts to disclose: she has received study medication from Pfizer for an NIMH trial, she has received support from Eli Lilly for an investigator-initiated grant and has received royalties from Up to Date. All other investigators do not have any conflicts of interest.

Figures

Fig. 1
Fig. 1
Consort diagram.
See this image and copyright information in PMC

Comment in

References

    1. Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007;196(6):544.e1. - PubMed
    1. Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60:720–726. - PubMed
    1. Zeskind P, Stephens L. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113(2):368–375. - PubMed
    1. Costei A, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002;156:1129–1132. - PubMed
    1. Sanz E, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005;365:482–487. - PubMed

Publication types

MeSH terms

Substances